Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences FACSCanto flow Cytometer and Living Colors pIRES2-DsRed-Express Vector

Premium

BD Biosciences released two products last week for cell-based assays.

On May 11, the company launched the FACSCanto flow cytometer for bench top flow analysis in immunology, cell biology, and drug discovery. The system builds upon technology present in the company's LSRII cell analyzer and FACSAria cell sorter.

According to an official statement, the FACSCanto has high-sensitivity optics, low sample-to-sample carryover, and processing rates of up to 10,000 events per second. In addition, the company said it designed the system for ease of use.

On May 12, the company announced the release of its Living Colors pIRES2-DsRed-Express vector for transfecting mammalian cells. The vector can be used to identify cells expressing a particular gene of interest by selecting cells exhibiting red fluorescence, the company said. The vector contains the internal ribosome entry site of the encephalomyocarditis virus, which allows the gene of interest and fluorescence coding region to be translated from a single mRNA.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.